ArticleThe journal of allergy and clinical immunology. Global2025

Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.

Hirsh D Komarow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.